Cytomegalovirus (CMV) continues to have a tremendous impact in solid organ
transplantation despite remarkable advances in its diagnosis, prevention and treatment. It …

Cytomegalovirus (CMV) is the most common infection after organ transplantation and has a
major impact on morbidity, mortality and graft survival. Optimal prevention, diagnosis and …

Cytomegalovirus (CMV) is one of the most common opportunistic infections that affect the
outcome of solid organ transplantation. This updated guideline from the American Society of …

Cytomegalovirus (CMV) is a ubiquitous herpes virus that infects the majority of humans (1).
The seroprevalence rates of CMV ranges from 30–97%(2, 3). Primary infection manifests as …

Cytomegalovirus (CMV) remains one of the most common infections after solid organ
transplantation, resulting in significant morbidity, graft loss, and occasional mortality …

Human cytomegalovirus (CMV), one of the eight herpesviruses that commonly infect
humans, is best known for its propensity to cause disease in immunocompromised patients …

Cytomegalovirus (CMV) continues to be one of the most important pathogens that
universally affect solid organ and allogeneic hematopoietic stem cell transplant recipients …

Human cytomegalovirus (HCMV) can cause severe diseases in fetuses, newborns, and
immunocompromised individuals. Currently, no vaccines are approved, and treatment …

Lung transplantation is a therapeutic option for patients with end-stage pulmonary disorders.
Unfortunately, due to post–lung transplant complications, both infectious and noninfectious …

Abstract The CMV Symposium in September 2021 was an international conference
dedicated to cytomegalovirus (CMV) infection after solid organ or hematopoietic stem cell …